Block
-
Amsbio: HAMA Blocker for Reduction of Immunoassay Interference
Amsbio has introduced TRU Block, a potent reagent that actively blocks the Heterophilic Antibody (HA) interference in immunoassays including but not limited to Human Anti-Mouse Antibody (HAMA) interference. The reagent offers advantages over tradi…
Block | 08 February 2010
-
Tyrosine kinase inhibitors to generate five blockbusters by 2013
A new study by Cutting Edge Information says tyrosine kinase inhibitors may have five oncology drugs with annual sales over $1 billion by 2013. This list of blockbuster oncology drugs includes Novartis' Gleevec. Annual sales of Gleevec are pr…
Block | 16 September 2008
-
Merck Will Obtain Blockbuster Antidiabetic Drug Sales By 2011
Decision Resources and Millennium Research Group have released a new report finding that Merck will obtain blockbuster antidiabetic drug sales in the type 2 diabetes market by 2011 due to the uptake of their DPP-IV inhibitor, Januvia. Januvia will…
Block | 23 October 2007
-
Technical Report on Heating Block Performance & Utility
Radleys have published a Technical Bulletin that describes a series of controlled heating tests comparing the heat-up times and energy consumption of its Heat-On heating blocks with another leading brand. Scientists are increasingly turning to sp…
Block | 13 July 2007
